VEGFA and breast cancer: Conversely to what has been reported so far, other studies highlighted a tumour-suppressor role for MSC-derived EVs, where they have been found to downregulate VEGF in BC cells, partially through miR-16 [94] and suppress angiogenesis through miR-100 [95].